Clinical Trials Logo

Clinical Trial Summary

Patients undergoing general anesthesia will have an endotracheal tube inserted. Adequate muscle strength recovery in the recovery room is crucial to ensure before extubation. One of the criteria we use to determine the recovery of muscle strength post-use of muscle relaxants in conditions without specific monitoring devices is the ability to maintain body oxygen levels without oxygen assistance for 3 minutes. This study aims to determine the muscle strength value in the recovery room using extubation strategies without muscle strength monitoring compared to extubation strategies with muscle strength monitoring.


Clinical Trial Description

The availability of Train-of-Four (TOF) monitoring devices is not yet widespread in some clinical practices. Practitioners are also often unaware of the high incidence of residual paralysis and the associated risks in their daily practice. However, residual paralysis increases the occurrence of airway obstruction, hypoxemia, and postoperative pulmonary complications. Therefore, clinical parameters for extubation criteria must ensure the absence of residual paralysis. Administering oxygen in the ambient air can identify hypoventilation conditions. Therefore, patients who can maintain oxygen saturation levels > 95% can be considered not experiencing hypoventilation. The author aims to validate ventilation adequacy as an additional clinical parameter for extubation criteria without TOF monitoring to ensure the absence of residual paralysis in the recovery room. This study is planned using a randomized controlled trial method with observer blinding. The study consists of 3 comparisons based on the type of volatile anesthetic gas agent and neuromuscular blockade agent. This research will involve 240 subjects aged 18-60 years undergoing elective surgery under intubation general anesthesia. Subjects will be divided into two parallel treatment groups randomly stratified by the type of surgery to observe the incidence rate of residual paralysis in the recovery room. Group A will receive extubation strategy without additional oxygen supplementation, while Group B will use extubation strategy with quantitative TOF monitoring. Group A will receive optimal reversal strategy using neostigmine based on clinical criteria such as tidal volume adequacy and the time of last administration of the neuromuscular blockade agent. Then, patients will be assessed 15 minutes after reversal for the ability to maintain oxygen saturation levels > 95% without oxygen supplementation. If they meet these criteria, patients will then be extubated. Group B will receive optimal reversal strategy using neostigmine based on TOF values. If the measured TOF value is ≥0.90, patients can be extubated while awake. Upon arrival in the recovery room, the TOF values of both groups will be measured and compared as the outcome of this study. The results of this study are expected to provide recommendations for extubation strategies based on clinical parameters to clinicians with limited access to TOF monitoring devices. With the implementation of this change in extubation strategy, unexpected post-anesthesia events may be reduced. ;


Study Design


Related Conditions & MeSH terms

  • Anesthesia Intubation Complication

NCT number NCT06275542
Study type Interventional
Source University of Surabaya
Contact
Status Enrolling by invitation
Phase N/A
Start date April 1, 2024
Completion date January 1, 2026

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03591432 - A Trial Comparing Transnasal humidified Rapid insufflation Ventilatory Exchange (THRIVE) and Apneic Oxygenation With Facemask Ventilation in Elderly Patients Undergoing Induction of Anaesthesia. N/A
Recruiting NCT01790646 - Learning and Performance of Glidescope® Videolaryngoscope Intubation N/A
Completed NCT01518608 - Alfentanil and the Elimination of Sympathetic Responses to Tracheal Intubation During Rapid Sequence Induction of Anesthesia: A Probability-based Approach Phase 4
Not yet recruiting NCT04268043 - Comparation of Proseal Laryngeal Mask Airway With Flexible Laryngeal Airway Mask N/A
Recruiting NCT03902704 - Safety and Efficacy of Cleverscope. A New Medical Device for Tracheal Intubation N/A
Completed NCT05383417 - No Post Intubation Laryngeal Symptoms N/A
Recruiting NCT04864106 - Comprehensive Preoperative Airway Grading N/A
Active, not recruiting NCT02627755 - GlideScope® vs GlideScope® + aScope® for Managing Difficult Airways. N/A
Not yet recruiting NCT06091631 - Magnesium Sulfate in Surgical Stress Attenuation Postoperative Sore Throat and Stress Response Induced Tracheal Intubation N/A
Completed NCT04085744 - A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff N/A
Completed NCT04802122 - Induction of Anesthesia With Sevoflurane Preserving Spontaneous Breathing: Cardiorespiratory Effects. Phase 4
Completed NCT05366582 - Neural Integrity Monitor Electromyogram (NIM-EMG) Endotracheal Tube Intubation With Video Laryngoscope N/A
Completed NCT03631875 - Co-induction Ketamine-propofol: Effects on Laryngeal Mask Airway Insertion Conditions in Children Phase 4
Completed NCT04110899 - Paratracheal Force Required for Occluding the Upper Esophagus N/A
Not yet recruiting NCT05279170 - MAsk VEntilation With Paratracheal Pressure In Children. Para Tracheal Compression to Prevent Gastric Insufflation in Children N/A
Completed NCT01289769 - The Effect of Dexmedetomidine on Hemodynamic Response During Double Lumen Endotracheal Intubation Phase 2
Completed NCT03833947 - Dexamethasone vs Bicarbonate to Intracuff Lignocaine 2% in General Anaesthesia Phase 4
Completed NCT04779528 - Awake Nasal Fiber-optic Intubation of Severely Obese Patients in Lateral Position N/A
Recruiting NCT05433155 - Nasotracheal Intubation With VL vs DL in Infants Trial N/A
Completed NCT05432570 - Use of Muscle Relaxants in Parotidectomy Operation With Neuromonitoring N/A